Your browser doesn't support javascript.
loading
YAP, but Not RSPO-LGR4/5, Signaling in Biliary Epithelial Cells Promotes a Ductular Reaction in Response to Liver Injury.
Planas-Paz, Lara; Sun, Tianliang; Pikiolek, Monika; Cochran, Nadire R; Bergling, Sebastian; Orsini, Vanessa; Yang, Zinger; Sigoillot, Frederic; Jetzer, Jasna; Syed, Maryam; Neri, Marilisa; Schuierer, Sven; Morelli, Lapo; Hoppe, Philipp S; Schwarzer, Wibke; Cobos, Carlos M; Alford, John L; Zhang, Le; Cuttat, Rachel; Waldt, Annick; Carballido-Perrig, Nicole; Nigsch, Florian; Kinzel, Bernd; Nicholson, Thomas B; Yang, Yi; Mao, Xiaohong; Terracciano, Luigi M; Russ, Carsten; Reece-Hoyes, John S; Gubser Keller, Caroline; Sailer, Andreas W; Bouwmeester, Tewis; Greenbaum, Linda E; Lugus, Jesse J; Cong, Feng; McAllister, Gregory; Hoffman, Gregory R; Roma, Guglielmo; Tchorz, Jan S.
Afiliación
  • Planas-Paz L; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Sun T; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Pikiolek M; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Cochran NR; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Cambridge, MA, USA.
  • Bergling S; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Orsini V; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Yang Z; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Cambridge, MA, USA.
  • Sigoillot F; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Cambridge, MA, USA.
  • Jetzer J; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Syed M; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Neri M; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Schuierer S; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Morelli L; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Hoppe PS; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Schwarzer W; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Cobos CM; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland; Hospital Aleman, Buenos Aires, Argentina.
  • Alford JL; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Cambridge, MA, USA.
  • Zhang L; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Cambridge, MA, USA.
  • Cuttat R; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Waldt A; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Carballido-Perrig N; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Nigsch F; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Kinzel B; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Nicholson TB; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Cambridge, MA, USA.
  • Yang Y; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Cambridge, MA, USA.
  • Mao X; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Cambridge, MA, USA.
  • Terracciano LM; Institute for Pathology, University Hospital Basel, Basel, Switzerland.
  • Russ C; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Cambridge, MA, USA.
  • Reece-Hoyes JS; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Cambridge, MA, USA.
  • Gubser Keller C; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Sailer AW; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Bouwmeester T; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Greenbaum LE; Novartis Institutes for Biomedical Research, Novartis Pharma AG, East Hanover, NJ, USA.
  • Lugus JJ; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Cambridge, MA, USA.
  • Cong F; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Cambridge, MA, USA.
  • McAllister G; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Cambridge, MA, USA.
  • Hoffman GR; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Cambridge, MA, USA.
  • Roma G; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Tchorz JS; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland. Electronic address: jan.tchorz@novartis.com.
Cell Stem Cell ; 25(1): 39-53.e10, 2019 07 03.
Article en En | MEDLINE | ID: mdl-31080135
ABSTRACT
Biliary epithelial cells (BECs) form bile ducts in the liver and are facultative liver stem cells that establish a ductular reaction (DR) to support liver regeneration following injury. Liver damage induces periportal LGR5+ putative liver stem cells that can form BEC-like organoids, suggesting that RSPO-LGR4/5-mediated WNT/ß-catenin activity is important for a DR. We addressed the roles of this and other signaling pathways in a DR by performing a focused CRISPR-based loss-of-function screen in BEC-like organoids, followed by in vivo validation and single-cell RNA sequencing. We found that BECs lack and do not require LGR4/5-mediated WNT/ß-catenin signaling during a DR, whereas YAP and mTORC1 signaling are required for this process. Upregulation of AXIN2 and LGR5 is required in hepatocytes to enable their regenerative capacity in response to injury. Together, these data highlight heterogeneity within the BEC pool, delineate signaling pathways involved in a DR, and clarify the identity and roles of injury-induced periportal LGR5+ cells.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Conductos Biliares / Proteínas de Ciclo Celular / Proteínas Adaptadoras Transductoras de Señales / Células Epiteliales / Lesión Pulmonar Aguda / Células Madre Pluripotentes Inducidas Límite: Animals / Humans / Male Idioma: En Revista: Cell Stem Cell Año: 2019 Tipo del documento: Article País de afiliación: Suiza

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Conductos Biliares / Proteínas de Ciclo Celular / Proteínas Adaptadoras Transductoras de Señales / Células Epiteliales / Lesión Pulmonar Aguda / Células Madre Pluripotentes Inducidas Límite: Animals / Humans / Male Idioma: En Revista: Cell Stem Cell Año: 2019 Tipo del documento: Article País de afiliación: Suiza